Search research articles
Contact Us
Filters
Showing results (81-90 of 117) with videos related to
Page
of 12
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 1, 1992
Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET
J Blin, M J Vidailhet, B Pillon, et al.
Neuropsychologia
|
February 20, 2003
The prefrontal cortex and conscious monitoring of action: an experimental study
A Slachevsky, B Pillon, P Fourneret, et al.
Neuropsychologia
|
April 9, 1998
Is impaired memory for spatial location in Parkinson's disease domain specific or dependent on 'strategic' processes?
B Pillon, B Deweer, M Vidailhet, et al.
Neuropsychologia
|
November 6, 2002
Motivation, reward, and Parkinson's disease: influence of dopatherapy
V Czernecki, B Pillon, J L Houeto, et al.
Neurology
|
August 1, 1995
The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease
B Pillon, J Blin, M Vidailhet, et al.
Archives of Neurology
|
July 1, 1990
Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations
J Blin, J C Baron, B Dubois, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 1, 1989
Increased wave P 300 latency in progressive supranuclear palsy
C Pierrot-Deseilligny, E Turell, C Penet, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 1, 1995
Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy
B Pillon, N Gouider-Khouja, B Deweer, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior
|
March 1, 1994
Explicit memory, procedural learning and lexical priming in Alzheimer's disease
B Deweer, A M Ergis, P Fossati, et al.
Clinical Neuropharmacology
|
May 14, 1998
Attentional deficits in Parkinson's disease: partial reversibility with naphtoxazine (SDZ NVI-085), a selective noradrenergic alpha 1 agonist
M A Bédard, F el Massioui, C Malapani, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 117) with videos related to
Sort By:
Page
of 12
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 1, 1992
Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET
J Blin, M J Vidailhet, B Pillon, et al.
Neuropsychologia
|
February 20, 2003
The prefrontal cortex and conscious monitoring of action: an experimental study
A Slachevsky, B Pillon, P Fourneret, et al.
Neuropsychologia
|
April 9, 1998
Is impaired memory for spatial location in Parkinson's disease domain specific or dependent on 'strategic' processes?
B Pillon, B Deweer, M Vidailhet, et al.
Neuropsychologia
|
November 6, 2002
Motivation, reward, and Parkinson's disease: influence of dopatherapy
V Czernecki, B Pillon, J L Houeto, et al.
Neurology
|
August 1, 1995
The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease
B Pillon, J Blin, M Vidailhet, et al.
Archives of Neurology
|
July 1, 1990
Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations
J Blin, J C Baron, B Dubois, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 1, 1989
Increased wave P 300 latency in progressive supranuclear palsy
C Pierrot-Deseilligny, E Turell, C Penet, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 1, 1995
Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy
B Pillon, N Gouider-Khouja, B Deweer, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior
|
March 1, 1994
Explicit memory, procedural learning and lexical priming in Alzheimer's disease
B Deweer, A M Ergis, P Fossati, et al.
Clinical Neuropharmacology
|
May 14, 1998
Attentional deficits in Parkinson's disease: partial reversibility with naphtoxazine (SDZ NVI-085), a selective noradrenergic alpha 1 agonist
M A Bédard, F el Massioui, C Malapani, et al.
Page
of 12